Stay updated on ALT-801 in Overweight and Obese T2DM: Clinical Trial
Sign up to get notified when there's something new on the ALT-801 in Overweight and Obese T2DM: Clinical Trial page.

Latest updates to the ALT-801 in Overweight and Obese T2DM: Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedAdded system revision note 'Revision: v3.4.2' and removed older maintenance notices (funding status and 'Revision: v3.4.1'). These changes affect only page metadata, not the study content.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a government funding lapse notice about NIH operations and a site revision indicator (v3.4.1); the previous revision tag (v3.4.0) was removed, and these changes do not alter trial data or study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a glossary display and updated footer labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0) to reflect a UI/metadata refresh; these changes are cosmetic and do not affect the study details on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision version updated from v3.3.3 to v3.3.4. Page content and layout appear unchanged.SummaryDifference0.1%

- Check63 days agoChange DetectedLocation information was updated: new site locations were added and existing site listings removed, the page revision was updated to v3.3.3, and the HHS Vulnerability Disclosure link was removed.SummaryDifference0.7%

- Check92 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to ALT-801 in Overweight and Obese T2DM: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALT-801 in Overweight and Obese T2DM: Clinical Trial page.